Stage 3 Uterine Cancer Prognosis
Stage 3 Uterine Cancer Prognosis Understanding the prognosis is crucial for individuals and their loved ones in order to make informed decisions about treatment and care.
As the disease progresses to Stage 3, the uterine cancer has grown beyond the uterus and may have spread to nearby tissues or lymph nodes. This advanced stage poses unique challenges and requires a comprehensive approach to treatment. By exploring the symptoms, diagnosis, and available treatment options, we aim to equip you with the information you need to face this diagnosis with courage and confidence.
Through this informative article, we will discuss the prognostic factors that influence the survival rates of Stage 3 Uterine Cancer. It is important to note that each individual’s prognosis can vary depending on various factors, including the extent of the disease, overall health, and response to treatment. By understanding the prognosis, individuals can work closely with their healthcare team to determine the most appropriate course of action.
Stay informed, hopeful, and supported as we delve into the details of Stage 3 Uterine Cancer. Together, we can navigate the challenges and explore the possibilities for a brighter future.
Understanding Stage 3 Uterine Cancer
Stage 3 Uterine Cancer is a significant advancement in the progression of the disease. Understanding the staging process and the implications of a Stage 3 diagnosis is essential for patients and their loved ones. Let’s explore the details of Stage 3 Uterine Cancer and gain a clearer understanding of its extent and progression.
Stage 3 Uterine Cancer Staging
Staging is crucial in determining the extent and spread of cancer within the body. In the case of Uterine Cancer, staging involves evaluating the size of the tumor, the involvement of nearby lymph nodes, and the presence of cancer in other organs or tissues.
The staging system commonly used for Uterine Cancer is the International Federation of Gynecology and Obstetrics (FIGO) system. According to this system, Stage 3 Uterine Cancer is divided into two subcategories:
- Stage 3A: Cancer has spread to the serosa, outermost layer of the uterus, or to the adnexal structures.
- Stage 3B: Cancer has invaded the vagina.
Proper staging is critical for determining the most appropriate treatment options and predicting the prognosis of Stage 3 Uterine Cancer.
Progression and Symptoms
As Uterine Cancer progresses to Stage 3, it typically signifies that the cancer has spread beyond the uterus to nearby tissues and organs. This may include the cervix, fallopian tubes, lymph nodes, and other pelvic structures.
At this stage, individuals may experience symptoms such as:
- Abnormal vaginal bleeding
- Pelvic pain or discomfort
- Feeling of pressure or fullness in the lower abdomen
- Changes in bowel or bladder habits
- Unexplained weight loss
Importance of Early Detection
Early detection and prompt medical attention are crucial in managing Stage 3 Uterine Cancer. Recognizing the symptoms and seeking medical care can lead to earlier diagnosis and a higher chance of successful treatment.
In the next section, we will explore the symptoms of Stage 3 Uterine Cancer in more detail, providing valuable insights for individuals who may be at risk or experiencing concerning symptoms.
Symptoms of Stage 3 Uterine Cancer
Recognizing the symptoms of Stage 3 Uterine Cancer is crucial for early detection and prompt medical attention. While symptoms may vary from person to person, below are some common signs to be aware of:
- Abnormal vaginal bleeding: This can include heavy or prolonged periods, bleeding between periods, or bleeding after menopause.
- Pelvic pain: Persistent pain in the pelvic region, including the lower abdomen, back, or legs, may be a symptom of Stage 3 Uterine Cancer.
- Unexplained weight loss: If you have experienced unintentional weight loss without changes in diet or exercise, it is essential to consult with a healthcare professional.
- Difficulty urinating: Stage 3 Uterine Cancer may cause urinary symptoms such as frequent urination, pain or discomfort while urinating, or urinary incontinence.
- Changes in bowel habits: This can include constipation, diarrhea, or other changes in bowel movements that are not attributed to other underlying causes.
- Abdominal swelling: A persistent bloated feeling or abdominal swelling that is not relieved with usual measures may be a symptom to be aware of.
It is important to note that experiencing these symptoms does not necessarily mean you have Stage 3 Uterine Cancer. However, if you are experiencing any of these symptoms or have concerns, it is essential to consult with your healthcare provider for a proper diagnosis.
| Symptom | Description |
|---|---|
| Abnormal vaginal bleeding | Includes heavy or prolonged periods, bleeding between periods, or bleeding after menopause. |
| Pelvic pain | Persistent pain in the pelvic region, including the lower abdomen, back, or legs. |
| Unexplained weight loss | Experiencing unintentional weight loss without changes in diet or exercise. |
| Difficulty urinating | Urinary symptoms such as frequent urination, pain or discomfort while urinating, or urinary incontinence. |
| Changes in bowel habits | Constipation, diarrhea, or other changes in bowel movements not attributed to other underlying causes. |
| Abdominal swelling | Persistent bloated feeling or abdominal swelling that is not relieved with usual measures. |
Diagnosis and Staging of Stage 3 Uterine Cancer
In order to accurately diagnose and stage Stage 3 Uterine Cancer, several tests and procedures are employed by medical professionals. These methods help determine the extent and progression of the disease, guiding appropriate treatment plans. Here, we will explore the diagnostic process and staging techniques used for Stage 3 Uterine Cancer.
Diagnostic Process
The diagnostic journey for Stage 3 Uterine Cancer typically begins with a thorough medical history review and physical examination. The healthcare provider will inquire about symptoms and risk factors associated with the disease. Based on the initial evaluation, further investigations may be recommended to confirm the diagnosis.
Imaging tests such as ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT) scans are commonly used to visualize the uterus and surrounding tissues. These tests can help identify any abnormalities, such as tumors or enlarged lymph nodes, which may indicate the presence of Stage 3 Uterine Cancer.
Additionally, a biopsy is often performed to obtain a tissue sample for microscopic examination. This procedure involves the removal of a small portion of the uterine tissue, which is then analyzed by a pathologist. The biopsy helps confirm the presence of cancer cells and determine the specific type of uterine cancer.
Staging Techniques
Once a diagnosis of Uterine Cancer Stage 3 is confirmed, staging is performed to determine the extent of the disease and inform treatment decisions. The staging process involves evaluating factors such as tumor size, lymph node involvement, and the presence of metastases.
The International Federation of Gynecology and Obstetrics (FIGO) system is commonly used to stage Uterine Cancer. This system classifies the disease into four main stages: I, II, III, and IV, with Stage 3 indicating that the cancer has spread beyond the uterus.
Staging for Uterine Cancer Stage 3 may involve additional imaging tests, such as positron emission tomography (PET) scans, to identify any distant metastases. These tests help determine if the cancer has spread to other organs or lymph nodes outside the pelvis.
Based on the results of the diagnostic tests and staging techniques, healthcare providers can stratify the disease into different categories, allowing for personalized treatment plans and prognostic assessments.
It is important for individuals diagnosed with Stage 3 Uterine Cancer to consult with a team of healthcare professionals experienced in the management of gynecologic cancers. The expertise and guidance of these specialists can significantly impact treatment decisions and overall outcomes.
Treatment Options for Stage 3 Uterine Cancer
When it comes to managing Stage 3 Uterine Cancer, there are several treatment options available. The choice of treatment will depend on various factors, including the extent of the cancer, the overall health of the patient, and the desired outcomes. The primary aim of treatment is to remove or destroy the cancer cells and reduce the risk of recurrence.
Surgery: Surgery is often the first-line treatment for Stage 3 Uterine Cancer. The goal of surgery is to remove the tumor, as well as any nearby lymph nodes or other affected tissues. The specific surgical procedure will depend on the individual case, but it may involve a hysterectomy (removal of the uterus), bilateral salpingo-oophorectomy (removal of the ovaries and fallopian tubes), and lymph node dissection.
Radiation therapy: Radiation therapy uses high-energy X-rays or other radiation sources to kill cancer cells or prevent their growth. It can be administered externally or internally. External beam radiation therapy targets the tumor from outside the body, while brachytherapy involves placing radioactive material inside the body near the tumor. Radiation therapy may be used before surgery to shrink the tumor or after surgery to kill any remaining cancer cells.
Chemotherapy: Chemotherapy involves the use of drugs to kill cancer cells or slow their growth. It is often used in combination with surgery or radiation therapy to enhance treatment effectiveness. Systemic chemotherapy is administered through the bloodstream and can reach cancer cells throughout the body. These drugs can help destroy any remaining cancer cells after surgery and reduce the risk of recurrence.
Targeted therapies: Targeted therapies are designed to specifically target certain molecules or pathways involved in cancer growth. These therapies work differently from chemotherapy and may have fewer side effects. They can be used alone or in combination with other treatments and are often recommended for advanced or recurrent cases of Stage 3 Uterine Cancer.
Each treatment option has its benefits and potential side effects. The choice of treatment will be determined by the patient’s specific condition and the recommendations of their healthcare team. It is important for patients to have a thorough discussion with their doctors to understand the potential risks and benefits of each treatment option.
| Treatment Option | Description | Potential Side Effects |
|---|---|---|
| Surgery | Removal of the tumor, lymph nodes, and affected tissues | Pain, bleeding, infection, hormonal changes |
| Radiation Therapy | Use of high-energy X-rays or radioactive material to kill cancer cells | Skin changes, fatigue, nausea, bowel or bladder problems |
| Chemotherapy | Use of drugs to kill or slow the growth of cancer cells | Nausea, hair loss, fatigue, increased risk of infection |
| Targeted Therapies | Specifically target molecules or pathways involved in cancer growth | Skin rash, diarrhea, liver problems, increased risk of blood clots |
Surgical Interventions for Stage 3 Uterine Cancer
When it comes to the treatment of Stage 3 Uterine Cancer, surgical interventions play a crucial role. Various types of surgeries are performed depending on the specific circumstances and goals of each patient. These interventions aim to remove the cancerous tissue and, in some cases, nearby lymph nodes to prevent the spread of the disease.
The key surgical interventions for Stage 3 Uterine Cancer include:
- Hysterectomy: This procedure involves the removal of the uterus and, in some cases, other reproductive organs such as the ovaries and fallopian tubes. It is commonly performed to eliminate the primary source of the cancer and prevent its further growth and spread.
- Lymphadenectomy: Also known as lymph node dissection, this surgery involves removing the lymph nodes in the pelvic area. It helps determine the spread of cancer and assists in staging the disease accurately.
- Omentectomy: In this procedure, the omentum (a fatty tissue layer covering the abdominal organs) is removed, especially when cancer has spread to this region. It aids in preventing further dissemination of the disease.
These surgical interventions are usually performed alongside other treatment modalities, such as radiation therapy or chemotherapy, to achieve the best possible outcomes for patients with Stage 3 Uterine Cancer. The specific approach taken depends on factors such as the patient’s overall health, the extent of the disease, and the recommendations of the medical team.
| Surgical Intervention | Goals | Potential Benefits |
|---|---|---|
| Hysterectomy | – Removal of the uterus and other reproductive organs – Elimination of the primary cancer source |
– Preventing further growth and spread of the cancer – Relief from symptoms such as abnormal bleeding and pain |
| Lymphadenectomy | – Removal of pelvic lymph nodes – Determining the extent of cancer spread |
– Accurate staging of the disease – Providing insights into further treatment options |
| Omentectomy | – Removal of the omentum – Prevention of cancer dissemination |
– Reducing the risk of cancer recurrence – Enhancing the effectiveness of other treatments |
Radiation Therapy for Stage 3 Uterine Cancer
When it comes to managing Stage 3 Uterine Cancer, radiation therapy is an important treatment option that plays a significant role in the patient’s journey. It involves using high-energy radiation to target and destroy cancer cells in the uterus and nearby areas. Radiation therapy can be administered externally or internally, depending on the individual’s specific needs and circumstances.
The Different Types of Radiation Therapy
There are several techniques employed in radiation therapy for Stage 3 Uterine Cancer, including:
- External Beam Radiation Therapy: This involves delivering radiation from a machine outside the body. The machine directs precise beams of radiation to the affected area, ensuring minimal damage to healthy tissues.
- Brachytherapy: In this technique, radioactive sources are placed inside the body, near the tumor site. This allows for a more targeted and higher dose of radiation to be delivered directly to the cancer cells.
The Benefits and Potential Side Effects
Radiation therapy offers several benefits in the management of Stage 3 Uterine Cancer. It can help shrink tumors, relieve symptoms, and improve overall survival rates. Additionally, radiation therapy is often used in conjunction with other treatments, such as surgery and chemotherapy, to increase the chances of successful outcomes.
However, it is important to note that radiation therapy can also have side effects. These may vary depending on the type and duration of treatment, as well as individual factors. Common side effects include fatigue, skin reactions, and gastrointestinal issues. It is crucial for patients to discuss potential side effects with their healthcare team and receive appropriate supportive care to minimize discomfort during treatment.
Radiation Therapy: An Integral Part of Managing Stage 3 Uterine Cancer
As part of the comprehensive treatment approach for Stage 3 Uterine Cancer, radiation therapy plays a crucial role. By targeting cancer cells directly and working in conjunction with other treatment modalities, it helps improve outcomes and enhance the quality of life for patients. To determine the most suitable radiation therapy plan, individuals should consult with their healthcare team, who will develop a personalized treatment approach tailored to their specific condition and needs.
| Advantages of Radiation Therapy | Potential Side Effects |
|---|---|
|
|
Chemotherapy and Targeted Therapies for Stage 3 Uterine Cancer
Chemotherapy and targeted therapies play a crucial role in the treatment of Stage 3 Uterine Cancer. These systemic treatment approaches are designed to target cancer cells throughout the body, helping to manage the disease and improve overall outcomes.
Treatment Options for Stage 3 Uterine Cancer
Chemotherapy involves the use of powerful drugs that can kill cancer cells or stop them from growing and dividing. This treatment is usually administered intravenously or as oral medication. Chemotherapy may be used before surgery to shrink the tumor, after surgery to kill remaining cancer cells, or as the primary treatment option for stage 3 uterine cancer.
Targeted therapies, on the other hand, are medications that specifically target certain molecules or proteins that are involved in cancer cell growth and survival. By targeting these specific pathways, targeted therapies can slow down or inhibit the growth of cancer cells while causing fewer side effects compared to traditional chemotherapy.
Managing Stage 3 Uterine Cancer
In managing Stage 3 Uterine Cancer, a combination of chemotherapy and targeted therapies may be used. This multimodal approach aims to attack the cancer from different angles and improve the chances of successful treatment. The specific treatment plan will depend on the individual patient’s case and factors such as tumor size, location, and overall health.
Chemotherapy and targeted therapies may be used in combination with other treatments such as surgery and radiation therapy to achieve the best outcomes for patients with Stage 3 Uterine Cancer. The goal is to control the disease, manage symptoms, and improve the quality of life for those affected.
Treatment Side Effects
Chemotherapy can cause side effects, such as hair loss, nausea, fatigue, and lowered blood cell counts. Targeted therapies may also have their own set of specific side effects. However, advances in supportive care have greatly improved the management of these side effects, and healthcare professionals work closely with patients to minimize discomfort and enhance overall well-being during treatment.
It is important for patients to discuss potential side effects and concerns with their healthcare team to ensure proper management and support throughout the treatment process.
| Treatment Option | Benefits | Considerations |
|---|---|---|
| Chemotherapy | Kills or slows the growth of cancer cells throughout the body | Possible side effects, requires multiple treatment sessions |
| Targeted Therapies | Specifically targets cancer cells, causing fewer side effects than chemotherapy | May not be effective in all cases, limited availability for certain subtypes of uterine cancer |
As with any cancer treatment, it is essential for patients to work closely with their medical team to determine the most appropriate treatment options for their specific case of Stage 3 Uterine Cancer. Every individual’s situation is unique, and personalized treatment plans offer the best chance for successful outcomes and improved quality of life.
Prognosis and Survival Rates for Stage 3 Uterine Cancer
In this section, we will explore the prognosis and survival rates associated with Stage 3 Uterine Cancer. Understanding the outlook and potential outcomes is crucial for individuals facing this advanced stage of the disease. Several factors can influence the prognosis, including the extent of the cancer, the response to treatment, and the overall health of the patient.
Prognosis of Stage 3 Uterine Cancer
When it comes to Stage 3 Uterine Cancer, the prognosis can vary from person to person. It is important to note that the prognosis refers to the likely course and outcome of the disease. The healthcare team will consider various factors, including the grade of the tumor, its size, and whether it has spread to nearby lymph nodes or other organs.
Factors influencing prognosis include:
- Tumor grade
- Tumor size and location
- Lymph node involvement
- Metastasis to other organs
Based on these factors, medical professionals will determine the overall stage of the cancer and provide a prognosis. It’s important to remember that these estimates are general and that each individual case is unique.
Survival Rates for Stage 3 Uterine Cancer
The survival rates for Stage 3 Uterine Cancer depend on several factors, including the type of uterine cancer, the stage at diagnosis, and the overall health of the patient. Survival rates are generally given in terms of a 5-year survival rate, which represents the percentage of people who survive for at least 5 years after diagnosis.
It’s essential to understand that survival rates are estimates based on large groups of people, and individual outcomes may vary. The healthcare team will assess the specific characteristics of each case to provide a more accurate prognosis.
Survival rates for Stage 3 Uterine Cancer can range from around 30% to 60%, depending on various factors and treatment options. The healthcare team will work closely with the patient to develop a tailored treatment plan that maximizes the chances of a positive outcome. The goal is to improve quality of life and extend survival.
For the most accurate and up-to-date information on prognosis and survival rates for Stage 3 Uterine Cancer, it is crucial to consult with a healthcare professional specializing in the field.
Managing Stage 3 Uterine Cancer
Managing Stage 3 Uterine Cancer can be a challenging journey, but with the right strategies and support, individuals can effectively navigate through this advanced stage of the disease. Here are practical tips and resources to help:
Self-Care
- Take care of your physical health by following a balanced and nutritious diet. Consult a registered dietitian for personalized dietary recommendations.
- Engage in regular exercise as tolerated. Consult your healthcare team for appropriate exercise guidelines.
- Manage stress through relaxation techniques such as deep breathing, meditation, or yoga.
- Ensure you get enough rest and prioritize sleep for optimal healing and recovery.
Building a Support Network
Having a strong support network can make a significant difference in managing Stage 3 Uterine Cancer. Consider the following:
- Lean on family and friends for emotional support.
- Join support groups for individuals with uterine cancer. These groups provide a platform to connect with others who have similar experiences and can offer guidance and encouragement.
- Seek professional counseling or therapy if needed. A mental health professional can help you cope with the emotional challenges of your diagnosis.
Stay Informed
Educate yourself about your condition and treatment options. Stay updated on the latest research, advancements, and clinical trials related to Stage 3 Uterine Cancer. Remember to consult your healthcare team for accurate and personalized information.
Advocate for Yourself
Be an active participant in your healthcare journey. Ask questions, seek second opinions, and ensure you have a clear understanding of your treatment plan and its potential outcomes. Advocate for your needs and preferences to receive the best possible care.
Follow-Up Care
Regular follow-up appointments with your healthcare team are essential to monitor your progress and address any concerns or side effects. Discuss a follow-up schedule with your healthcare provider to ensure comprehensive and ongoing care.
Resources
Explore the following resources for additional information and support:
- Acibadem Healthcare Group – A leading provider of comprehensive care and innovative treatment options for individuals with Stage 3 Uterine Cancer.
- National Uterine Cancer Society – Offers educational materials, support groups, and resources.
- CancerCare – Provides counseling and support services for individuals affected by cancer.
Remember that managing Stage 3 Uterine Cancer is a collaborative effort between you, your healthcare team, and your support network. By taking a proactive approach and utilizing available resources, you can navigate this journey with strength and resilience.
Seeking Expert Care at Acibadem Healthcare Group
If you or a loved one has been diagnosed with Stage 3 Uterine Cancer, finding the right healthcare provider is essential for comprehensive care and effective treatment. At Acibadem Healthcare Group, we are dedicated to providing the highest level of expertise and personalized care for individuals with this advanced stage of uterine cancer.
Acibadem Healthcare Group is renowned for its commitment to patient-centered care and innovative treatment options. Our experienced medical professionals specialize in the diagnosis and management of Stage 3 Uterine Cancer, ensuring that each patient receives a tailored treatment plan based on their specific needs and circumstances.Stage 3 Uterine Cancer Prognosis
With state-of-the-art facilities and cutting-edge technology, Acibadem Healthcare Group offers a wide range of treatment modalities, including surgery, radiation therapy, chemotherapy, and targeted therapies. Our multidisciplinary team of experts collaborates closely to provide integrated care, combining the latest advancements in medical science with a compassionate approach.
At Acibadem Healthcare Group, we understand the challenges and complexities associated with Stage 3 Uterine Cancer. Our goal is to empower patients with knowledge, support, and effective treatment options to improve their quality of life and prognosis. Trust the expertise and dedication of Acibadem Healthcare Group to guide you through your journey towards healing and recovery.
FAQ
What is the prognosis for Stage 3 Uterine Cancer?
The prognosis for Stage 3 Uterine Cancer depends on various factors, including the extent of cancer spread, overall health, and response to treatment. Survival rates for Stage 3 Uterine Cancer can vary, with some individuals experiencing long-term remission or even a cure, while others may have a more challenging prognosis. It is essential to consult with a healthcare provider to understand individual prognosis and discuss treatment options.
What is Stage 3 Uterine Cancer?
Stage 3 Uterine Cancer is an advanced stage of the disease where cancer has invaded the outermost layer of the uterus and may have spread to nearby pelvic organs or lymph nodes. It signifies further progression from earlier stages and requires a comprehensive treatment approach.
What are the symptoms of Stage 3 Uterine Cancer?
The symptoms of Stage 3 Uterine Cancer can vary, but common signs may include abnormal vaginal bleeding, pelvic pain or discomfort, back pain, weight loss, bloating, and changes in urination or bowel habits. It is important to note that these symptoms can also be associated with other conditions, so it's important to consult a healthcare provider for an accurate diagnosis.
How is Stage 3 Uterine Cancer diagnosed and staged?
The diagnosis and staging of Stage 3 Uterine Cancer typically involve a combination of medical history evaluation, physical examination, imaging tests (such as CT scans or MRI), biopsy, and surgical procedures. These diagnostic measures enable healthcare professionals to determine the extent of cancer spread and assign a stage based on the TNM staging system.
What are the treatment options for Stage 3 Uterine Cancer?
Treatment options for Stage 3 Uterine Cancer may include surgery, radiation therapy, chemotherapy, targeted therapies, or a combination of these approaches. The precise treatment plan will depend on individual factors such as cancer stage, overall health, and treatment goals. Consulting with a multidisciplinary team of healthcare providers will help determine the most suitable treatment approach.
What are the surgical interventions for Stage 3 Uterine Cancer?
Surgical interventions for Stage 3 Uterine Cancer can include a hysterectomy (removal of the uterus), bilateral salpingo-oophorectomy (removal of the fallopian tubes and ovaries), lymph node dissection, or debulking surgery to remove visible tumors. The specific surgical approach will depend on the individual's unique circumstances and treatment goals.
How is radiation therapy used in the treatment of Stage 3 Uterine Cancer?
Radiation therapy is often used as part of the treatment plan for Stage 3 Uterine Cancer. It involves the use of high-energy X-rays or other sources of radiation to kill cancer cells or shrink tumors. The specific technique and duration of radiation therapy will depend on individual factors and treatment goals.
What are the chemotherapy and targeted therapy options for Stage 3 Uterine Cancer?
Chemotherapy and targeted therapies are systemic treatment options that can be utilized to manage Stage 3 Uterine Cancer. Chemotherapy involves the use of drugs that target rapidly dividing cells, including cancer cells. Targeted therapies, on the other hand, focus on specific molecular targets within cancer cells. The choice of chemotherapy or targeted therapy will depend on individual factors and treatment goals.
What are the prognosis and survival rates for Stage 3 Uterine Cancer?
The prognosis and survival rates for Stage 3 Uterine Cancer can vary depending on individual factors. Generally, the prognosis is better when the cancer is localized and has not spread extensively. However, it is important to note that survival rates are estimates and can vary widely between individuals. A comprehensive evaluation by a healthcare professional is crucial for a more accurate prognosis.
How can Stage 3 Uterine Cancer be managed?
Managing Stage 3 Uterine Cancer requires a comprehensive treatment approach tailored to the individual's specific circumstances. This may include a combination of surgery, radiation therapy, chemotherapy, targeted therapies, supportive care, and lifestyle modifications. Additionally, emotional support, counseling, and participation in support groups can help individuals cope with the challenges associated with this advanced stage of the disease.
How can Acibadem Healthcare Group help with Stage 3 Uterine Cancer?
Acibadem Healthcare Group offers expertise in the diagnosis, treatment, and management of Stage 3 Uterine Cancer. With a multidisciplinary team of healthcare professionals, state-of-the-art facilities, and innovative treatment options, Acibadem Healthcare Group is dedicated to providing comprehensive care and support to individuals with Stage 3 Uterine Cancer.
